Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
Translational Cancer Research|May 16, 2022
GABRP is a potential prognostic biomarker and correlated with immune infiltration and tumor microenvironment in pancreatic cancerYihui Yang, Liwen Ren, Sha Li, et al.
Cancer Biology & Medicine|September 29, 2021
Tumorigenic bacteria in colorectal cancer: mechanisms and treatmentsSha Li, Jinyi Liu, Xiangjin Zheng, et al.
Acta Pharmaceutica Sinica. B|September 30, 2021
The biology, function, and applications of exosomes in cancerJinyi Liu, Liwen Ren, Sha Li, et al.
Acta Pharmaceutica Sinica. B|December 13, 2021
Sinomenine ester derivative inhibits glioblastoma by inducing mitochondria-dependent apoptosis and autophagy by PI3K/AKT/mTOR and AMPK/mTOR pathwayXiangjin Zheng, Wan Li, Huanli Xu, et al.
Clinical Epigenetics|May 26, 2018
miR-29c plays a suppressive role in breast cancer by targeting the TIMP3/STAT1/FOXO1 pathwayWan Li, Jie Yi, Xiangjin Zheng, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|February 22, 2023
GABAergic signaling as a potential therapeutic target in cancersYihui Yang, Liwen Ren, Wan Li, et al.
Pharmacological Research|May 16, 2022
Anti-tumor effects of Skp2 inhibitor AAA-237 on NSCLC by arresting cell cycle at G0/G1 phase and inducing senescenceJinyi Liu, Xiangjin Zheng, Wan Li, et al.
Acta Pharmaceutica Sinica. B|December 23, 2022
Sphingosine kinase 1 promotes growth of glioblastoma by increasing inflammation mediated by the NF-κB /IL-6/STAT3 and JNK/PTX3 pathwaysWan Li, Hongqing Cai, Liwen Ren, et al.
Cellular Oncology (Dordrecht, Netherlands)|August 14, 2024
Interferon Gamma Inducible Protein 30: from biological functions to potential therapeutic target in cancersSen Zhang, Liwen Ren, Wan Li, et al.
Innovation (Cambridge (Mass.))|November 21, 2025
IFI30 promotes tumor-associated macrophage infiltration via activation of the ATF3-CCL5 axis in breast cancerLiwen Ren, Yihui Yang, Wan Li, et al.
Pageof 4